# AGAP2

## Overview
AGAP2, or ArfGAP with GTPase domain, ankyrin repeat, and PH domain 2, is a gene that encodes a multifunctional protein involved in various cellular processes, including membrane trafficking, signal transduction, and cytoskeletal remodeling. The protein encoded by AGAP2 is categorized as a GTPase-activating protein (GAP) and is characterized by its multidomain structure, which includes a GTP-binding protein-like domain, a pleckstrin homology domain, an Arf GAP domain, and ankyrin repeat domains. These domains facilitate its interactions with other proteins and its involvement in critical cellular functions such as vesicle formation, receptor trafficking, and kinase activity regulation. AGAP2 plays a significant role in cell proliferation, survival, and migration, and its dysregulation has been implicated in various pathological conditions, including cancer and fibrotic diseases (NavarroCorcuera2020AGAP2:; Doush2019SP1).

## Structure
AGAP2 is a multidomain protein characterized by several distinct domains that contribute to its function. The primary structure of AGAP2 includes a GTP-binding protein-like domain (GLD), a pleckstrin homology domain (PH), an Arf GAP domain with a zinc-binding motif, and ankyrin repeat domains (Ank) (Nie2005The). These domains are crucial for its role in cellular processes such as membrane trafficking and signal transduction. The PH domain is particularly important for binding phosphoinositides, which influences AGAP2's targeting and activity (Nie2005The).

AGAP2 interacts with various proteins, including β-arrestins, through its PH2 domain, which is essential for its GAP activity and is regulated by phospholipids (Wu2013The). The protein's interaction with adaptor protein complexes, such as AP-1, is mediated by the PH domain, which also binds to phosphoinositides (Nie2005The). AGAP2 is involved in retrograde transport between early endosomes and the trans-Golgi network, interacting with the clathrin machinery and affecting the distribution of proteins like the transferrin receptor (Shiba2010AGAP2).

AGAP2 may undergo post-translational modifications and exists in multiple splice variant isoforms, which could affect its function and interactions. However, specific details on the secondary, tertiary, or quaternary structures of AGAP2 are not provided in the available context.

## Function
AGAP2, also known as ArfGAP with GTPase domain, ankyrin repeat, and PH domain 2, is a multifunctional protein involved in various cellular processes in healthy human cells. It acts as a GTPase-activating protein (GAP) for ADP-ribosylation factor (Arf) proteins, which are crucial for vesicle formation and transport, thereby playing a significant role in membrane trafficking and actin cytoskeleton remodeling (NavarroCorcuera2020AGAP2:). AGAP2 is primarily located in the cytoplasm and is associated with the Golgi apparatus, where it influences cell proliferation, survival, and migration (NavarroCorcuera2020AGAP2:).

The protein is involved in the regulation of kinase activity, particularly by binding to active AKT and up-regulating its kinase activity in a GTP-dependent manner, which is important for cell survival and signaling pathways such as phosphoinositide 3-kinase (PI3K) and protein kinase B (AKT) (NavarroCorcuera2020AGAP2:). AGAP2 also plays a role in receptor trafficking, including the recycling of TGF Receptor 2 (TGFR2) and glucose transporter 4 (GLUT4), which are essential for maintaining signaling pathways and cellular responses to stimuli (NavarroCorcuera2020AGAP2:). Through these functions, AGAP2 contributes to the internal organization, division, and migration of cells, highlighting its importance in maintaining cellular homeostasis.

## Clinical Significance
Alterations in the expression of the AGAP2 gene have been implicated in various cancers. AGAP2 is considered a proto-oncogene and is involved in processes such as cell survival, apoptosis, and migration. Its expression is notably increased in several cancers, including prostate cancer and glioblastoma, where it is associated with tumor progression (Doush2019SP1). In glioblastoma, AGAP2 overexpression is sometimes linked to the amplification of the CDK4 amplicon, and their co-expression drives tumor progression (Doush2019SP1). In chronic myeloid leukemia (CML) and prostate cancer, AGAP2 expression is regulated by the transcription factor SP1, and its silencing has been shown to decrease cell proliferation, particularly in prostate cancer cells (Doush2019SP1).

AGAP2 is also involved in fibrogenic processes, particularly in liver fibrosis. It alters TGFβ receptor II trafficking, which affects TGFβ1-induced gene expression changes, including collagen type I production. AGAP2 knockdown reduces collagen type I levels, suggesting its role in fibrotic diseases (NavarroCorcuera2019Role). The gene's involvement in receptor trafficking and its interaction with FAK and ERK pathways further implicate it in the regulation of fibrogenic gene expression and extracellular matrix deposition (NavarroCorcuera2019Role).

## Interactions
AGAP2 interacts with a variety of proteins, playing significant roles in cellular signaling and trafficking. It binds and stabilizes AKT in its active conformation, enhancing AKT activity and inhibiting programmed cell death (Doush2019SP1; NavarroCorcuera2020AGAP2:). AGAP2 also interacts with β-arrestin proteins, particularly β-arrestin2, influencing β2-adrenergic receptor (β2AR) recycling and ERK activation (Wu2013The). This interaction is facilitated by the PH2 domain of AGAP2 and is modulated by phospholipids like PtdIns(4,5)P2 (Wu2013The).

AGAP2 binds to the adaptor protein complex AP-1, inhibiting its GAP activity in a concentration-dependent manner, and this interaction is enhanced in the presence of clathrin (Nie2005The). AGAP2 also associates with STAT5a, promoting its interaction with the prolactin receptor, and binds to AMPK when phosphorylated by Fyn, leading to repression in its signaling pathway (Doush2019SP1).

In neurons, AGAP2 interacts with proteins in both postsynaptic density (PSD) and non-PSD compartments, associating with kinases and proteins involved in GTP signaling, which are crucial for actin cytoskeleton remodeling and neurite outgrowth (Wilkinson2017Synaptic). These interactions highlight AGAP2's multifaceted role in cellular processes such as cell survival, migration, and receptor trafficking.


## References


[1. (NavarroCorcuera2019Role) Amaia Navarro-Corcuera, María J. López-Zabalza, Juan J. Martínez-Irujo, Gloria Álvarez-Sola, Matías A. Ávila, María J. Iraburu, Eduardo Ansorena, and Cristina Montiel-Duarte. Role of agap2 in the profibrogenic effects induced by tgfβ in lx-2 hepatic stellate cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1866(4):673–685, April 2019. URL: http://dx.doi.org/10.1016/j.bbamcr.2019.01.008, doi:10.1016/j.bbamcr.2019.01.008. This article has 14 citations.](https://doi.org/10.1016/j.bbamcr.2019.01.008)

[2. (Nie2005The) Zhongzhen Nie, Jiajing Fei, Richard T. Premont, and Paul A. Randazzo. The arf gaps agap1 and agap2 distinguish between the adaptor protein complexes ap-1 and ap-3. Journal of Cell Science, 118(15):3555–3566, August 2005. URL: http://dx.doi.org/10.1242/jcs.02486, doi:10.1242/jcs.02486. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.02486)

[3. (Doush2019SP1) Yegor Doush, Arif A. Surani, Amaia Navarro-Corcuera, Stephanie McArdle, E. Ellen Billett, and Cristina Montiel-Duarte. Sp1 and rarα regulate agap2 expression in cancer. Scientific Reports, January 2019. URL: http://dx.doi.org/10.1038/s41598-018-36888-x, doi:10.1038/s41598-018-36888-x. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-018-36888-x)

[4. (Wu2013The) Yuanjun Wu, Yu Zhao, Xiaojie Ma, Yunjuan Zhu, Jaimin Patel, and Zhongzhen Nie. The arf gap agap2 interacts with β-arrestin2 and regulates β2-adrenergic receptor recycling and erk activation. Biochemical Journal, 452(3):411–421, May 2013. URL: http://dx.doi.org/10.1042/bj20121004, doi:10.1042/bj20121004. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20121004)

[5. (Shiba2010AGAP2) Yoko Shiba, Winfried Römer, Gonzalo A. Mardones, Patricia V. Burgos, Christophe Lamaze, and Ludger Johannes. Agap2 regulates retrograde transport between early endosomes and the tgn. Journal of Cell Science, 123(14):2381–2390, July 2010. URL: http://dx.doi.org/10.1242/jcs.057778, doi:10.1242/jcs.057778. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.057778)

[6. (Wilkinson2017Synaptic) Brent Wilkinson, Jing Li, and Marcelo P. Coba. Synaptic gap and gef complexes cluster proteins essential for gtp signaling. Scientific Reports, July 2017. URL: http://dx.doi.org/10.1038/s41598-017-05588-3, doi:10.1038/s41598-017-05588-3. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-05588-3)

[7. (NavarroCorcuera2020AGAP2:) Amaia Navarro-Corcuera, Eduardo Ansorena, Cristina Montiel-Duarte, and María J. Iraburu. Agap2: modulating tgfβ1-signaling in the regulation of liver fibrosis. International Journal of Molecular Sciences, 21(4):1400, February 2020. URL: http://dx.doi.org/10.3390/ijms21041400, doi:10.3390/ijms21041400. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21041400)